HB1424 (2020) Detail

(New Title) allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.


HB 1424 - AS AMENDED BY THE HOUSE

 

11Mar2020... 0630h

2020 SESSION

20-2298

01/04

 

HOUSE BILL 1424

 

AN ACT allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.

 

SPONSORS: Rep. W. Thomas, Hills. 21; Rep. Conley, Straf. 13; Rep. DesMarais, Carr. 6; Rep. Josephson, Graf. 11; Rep. Coursin, Rock. 1; Rep. Stack, Hills. 21; Rep. Cannon, Straf. 18; Rep. Amanda Bouldin, Hills. 12; Rep. Kenney, Straf. 6

 

COMMITTEE: Health, Human Services and Elderly Affairs

 

-----------------------------------------------------------------

 

AMENDED ANALYSIS

 

This bill allows alternative treatment centers to acquire and use in manufacturing  hemp-derived cannabidiol (CBD) isolate.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

11Mar2020... 0630h 20-2298

01/04

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Twenty

 

AN ACT allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1  New Paragraph; Use of Cannabis for Therapeutic Purposes; Alternative Treatment Centers; Requirements.  Amend RSA 126-X:8 by inserting after paragraph XVIII the following new paragraph:

XIX.  An alternative treatment center may acquire, and may use in the manufacture of cannabis concentrate and cannabis infused products, hemp-derived cannabidiol, or CBD, isolate that is not produced by an alterative treatment center in New Hampshire.  All such CBD isolate, and all cannabis concentrate and cannabis infused products manufactured from such CBD isolate, shall be tested for contaminants and cannabinoid profile in accordance with this chapter and department rules.

2  Effective Date.  This act shall take effect 60 days after its passage.

Links

HB1424 at GenCourtMobile
HB1424 Discussion

Action Dates

Date Body Type
Jan. 29, 2020 House Hearing
Feb. 13, 2020 House Exec Session
Feb. 18, 2020 House Exec Session
Feb. 18, 2020 House Exec Session
House Floor Vote
March 11, 2020 House Floor Vote

Bill Text Revisions

HB1424 Revision: 8290 Date: March 11, 2020, 3:34 p.m.
HB1424 Revision: 7052 Date: Dec. 3, 2019, 8:58 a.m.

Docket

Date Status
Jan. 8, 2020 Introduced 01/08/2020 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 21
Jan. 29, 2020 Public Hearing: 01/29/2020 11:00 am LOB 205
Feb. 12, 2020 Subcommittee Work Session: 02/12/2020 10:00 am LOB 104
Feb. 13, 2020 ==RECESSED== Executive Session: 02/13/2020 11:00 am LOB 205
Feb. 18, 2020 Subcommittee Work Session: 02/18/2020 10:00 am LOB 209 (if not exec'd on the 13th)
Feb. 18, 2020 ==CONTINUED== Executive Session: 02/18/2020 01:00 pm LOB 205 (if not exec'd on the 13th)
Committee Report: Ought to Pass with Amendment # 2020-0630h (Vote 19-1; CC)
March 11, 2020 Committee Report: Ought to Pass with Amendment # 2020-0630h (NT) for 03/11/2020 (Vote 19-1; CC) HC 10 P. 19
March 11, 2020 Amendment # 2020-0630h (NT): AA VV 03/11/2020
March 11, 2020 Ought to Pass with Amendment 2020-0630h (NT): MA VV 03/11/2020